Bill Hawkins predicts “mild pain” after the FDA’s 510(k) overhaul

Medtronic’s Hawkins: 510(k) changes to be ‘neutral to slightly negative’ (MedCityNews)
Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins is predicting only mild pain when the federal government unveils changes to the 510(k) rules governing approval for most medical devices.
...


Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.